1. Assessment of the 4‐factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. Issue 5 (24th February 2021) Authors: Morabito, Fortunato; Tripepi, Giovanni; Del Poeta, Giovanni; Mauro, Francesca Romana; Reda, Gianluigi; Sportoletti, Paolo; Laurenti, Luca; Coscia, Marta; Herishanu, Yair; Varettoni, Marzia; Murru, Roberta; Chiarenza, Annalisa; Visentin, Andrea; Condoluci, Adalgisa; Moia, Riccardo; Pietrasanta, Da... Journal: American journal of hematology Issue: Volume 96:Issue 5(2021) Page Start: E168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone. Issue 2 (2nd October 2012) Authors: Marasca, Roberto; Maffei, Rossana; Martinelli, Silvia; Fiorcari, Stefania; Bulgarelli, Jenny; Debbia, Giulia; Rossi, Davide; Rossi, Francesca Maria; Rigolin, Gian Matteo; Martinelli, Sara; Gattei, Valter; Del Poeta, Giovanni; Laurenti, Luca; Forconi, Francesco; Montillo, Marco; Gaidano, Gianluca;... Journal: Hematological oncology Issue: Volume 31:Issue 2(2013:Jun.) Page Start: 348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical significance of c.7544‐7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia. (20th November 2012) Authors: Del Poeta, Giovanni; Dal Bo, Michele; Del Principe, Maria Ilaria; Pozzo, Federico; Rossi, Francesca Maria; Zucchetto, Antonella; Bomben, Riccardo; Degan, Massimo; Rasi, Silvia; Rossi, Davide; Bulian, Pietro; Gaidano, Gianluca; Amadori, Sergio; Gattei, Valter Journal: British journal of haematology Issue: Volume 160:Number 3(2013:Feb.) Page Start: 415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparison of ibrutinib and idelalisib plus rituximab in real‐life relapsed/resistant chronic lymphocytic leukemia cases. (28th January 2021) Authors: Morabito, Fortunato; Tripepi, Giovanni; Del Poeta, Giovanni; Mauro, Francesca Romana; Reda, Gianluigi; Sportoletti, Paolo; Laurenti, Luca; Coscia, Marta; Herishanu, Yair; Bossio, Sabrina; Varettoni, Marzia; Murru, Roberta; Chiarenza, Annalisa; Visentin, Andrea; Condoluci, Adalgisa; Moia, Riccardo... Journal: European journal of haematology Issue: Volume 106:Number 4(2021) Page Start: 493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. COVID‐19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients. Issue 5 (30th August 2021) Authors: Del Poeta, Giovanni; Bomben, Riccardo; Polesel, Jerry; Rossi, Francesca Maria; Pozzo, Federico; Zaina, Eva; Cattarossi, Ilaria; Varaschin, Paola; Nanni, Paola; Boschian Boschin, Romina; Postorino, Massimiliano; Laureana, Roberta; Pasqualone, Gianmario; Steffan, Agostino; Gentile, Massimo; Zucchet... Journal: Hematological oncology Issue: Volume 39:Issue 5(2021) Page Start: 712 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effectiveness of ibrutinib as first‐line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab‐bendamustine: Results of study on 486 cases outside clinical trials. Issue 8 (3rd May 2021) Authors: Morabito, Fortunato; Tripepi, Giovanni; Del Poeta, Giovanni; Mauro, Francesca Romana; Reda, Gianluigi; Sportoletti, Paolo; Laurenti, Luca; Coscia, Marta; Herishanu, Yair; Bossio, Sabrina; Varettoni, Marzia; Murru, Roberta; Chiarenza, Annalisa; Visentin, Andrea; Condoluci, Adalgisa; Moia, Riccardo... Journal: American journal of hematology Issue: Volume 96:Issue 8(2021) Page Start: E269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Elastin MIcrofibriL INterfacer1 (EMILIN‐1) is an alternative prosurvival VLA‐4 ligand in chronic lymphocytic leukemia. Issue 2 (22nd November 2021) Authors: Tissino, Erika; Pivetta, Eliana; Capuano, Alessandra; Capasso, Guido; Bomben, Riccardo; Caldana, Chiara; Rossi, Francesca Maria; Pozzo, Federico; Benedetti, Dania; Boldorini, Renzo; Gaidano, Gianluca; Rossi, Davide; Zamò, Alberto; Hartmann, Tanja Nicole; Doliana, Roberto; Colombatti, Alfonso; Gat... Journal: Hematological oncology Issue: Volume 40:Issue 2(2022) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus‐related diseases. (29th December 2020) Authors: De Re, Valli; Tornesello, Maria Lina; De Zorzi, Mariangela; Caggiari, Laura; Pezzuto, Francesca; Leone, Patrizia; Racanelli, Vito; Lauletta, Gianfranco; Zanussi, Stefania; Repetto, Ombretta; Gragnani, Laura; Rossi, Francesca Maria; Dolcetti, Riccardo; Zignego, Anna Linda; Buonaguro, Franco M.; St... Journal: Liver international Issue: Volume 41:Number 1(2021) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases. Issue 8 (25th May 2021) Authors: Morabito, Fortunato; Del Poeta, Giovanni; Mauro, Francesca Romana; Reda, Gianluigi; Sportoletti, Paolo; Laurenti, Luca; Coscia, Marta; Herishanu, Yair; Bossio, Sabrina; Varettoni, Marzia; Murru, Roberta; Chiarenza, Annalisa; Visentin, Andrea; Condoluci, Adalgisa; Moia, Riccardo; Pietrasanta, Dani... Journal: American journal of hematology Issue: Volume 96:Issue 8(2021) Page Start: E306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗